Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development

被引:26
作者
Basille, M
Cartier, D
Vaudry, D
Lihrmann, I
Fournier, A
Freger, P
Gallo-Payet, N
Vaudry, H [1 ]
Gonzalez, B
机构
[1] Univ Rouen, INSERM, U413,European Inst Peptide Res, Lab Cellular & Mol Neuroendocrinol,IFRMP 23, F-76821 Mont St Aignan, France
[2] Univ Quebec, Inst Natl Rech Sci Sante, Inst Armand Frappier, Pointe Claire, PQ H9R 1G6, Canada
[3] Charle Nicolle Univ Hosp, Dept Neurosurg, F-76000 Rouen, France
[4] Univ Sherbrooke, Fac Med, Serv Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
关键词
neuropeptides; ontogeny; in situ hybridization; binding sites; pituitary adenylate cyclase-activating polypeptide receptor 1; vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors 1 and 2; cerebellar cortex;
D O I
10.1002/cne.20934
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pituitary adenylate cyclase-activating polypeptide (PACAP) receptors are actively expressed in the cortical layers of the cerebellum of rodents and contribute to cerebellar development. The present report provides the first anatomical localization and characterization of PACAP receptors in the developing human cerebellum. RT-PCR analysis from 15-week-old fetuses to 22-year-old subject showed that PAC1-R and VPAC1-R are expressed in the cerebellum at all stages, whereas VPAC2-R mRNA was barely detectable. In situ hybridization labeling indicated that, in human fetuses, PAC1-R mRNA is associated with the external granule cell layer (EGL), a germinative neuroepithelium, and with the internal granule cell layer (IGL). The distribution pattern of VPAC1-R mRNA was very similar to that of PAC1-R mRNA, whereas VPAC2-R mRNA was visualized only in 7-22-year-old subjects. The localization of [I-125]PACAP27 binding sites was fully consistent with the distribution of PAC1-R and VPAC1-R mRNA. Pharmacological characterization revealed that, in the EGL and IGL from 15-24-week-old fetuses and in the granule cell layer from 7-22-year-old patients, binding sites exhibit a PAC1-R profile. In contrast, PACAP binding sites observed in the molecular layer and medulla of the adult cerebellum consisted of a heterogeneous population of PAC1-R and VPAC(1/2)-R. Altogether, these data provide the first evidence that PACAP receptors are expressed in the human cerebellar cortex. PAC1-R is the predominant PACAP receptor found in fetuses, and both PAC1-R and VPAC1-R are expressed in the mature cerebellum. These observations suggest that PACAP has neurodevelopmental functions in the human cerebellum.
引用
收藏
页码:468 / 478
页数:11
相关论文
共 45 条
[1]   CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-2 RECEPTOR [J].
ADAMOU, JE ;
AIYAR, N ;
VANHORN, S ;
ELSHOURBAGY, NA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) :385-392
[2]   Novel splice variants, of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance [J].
Alexandre, D ;
Vaudry, H ;
Grumolato, L ;
Turquier, V ;
Fournier, A ;
Jégou, S ;
Anouar, Y .
ENDOCRINOLOGY, 2002, 143 (07) :2680-2692
[3]   LOCALIZATION AND CHARACTERIZATION OF PACAP RECEPTORS IN THE RAT CEREBELLUM DURING DEVELOPMENT - EVIDENCE FOR A STIMULATORY EFFECT OF PACAP ON IMMATURE CEREBELLAR GRANULE CELLS [J].
BASILLE, M ;
GONZALEZ, BJ ;
LEROUX, P ;
JEANDEL, L ;
FOURNIER, A ;
VAUDRY, H .
NEUROSCIENCE, 1993, 57 (02) :329-338
[4]  
Basille M, 2000, J COMP NEUROL, V425, P495
[5]   ONTOGENY OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) RECEPTORS IN THE RAT CEREBELLUM - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
BASILLE, M ;
GONZALEZ, BJ ;
FOURNIER, A ;
VAUDRY, H .
DEVELOPMENTAL BRAIN RESEARCH, 1994, 82 (1-2) :81-89
[6]   VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells [J].
Cazillis, M ;
Gonzalez, BJ ;
Billardon, C ;
Lombet, A ;
Fraichard, A ;
Samarut, J ;
Gressens, P ;
Vaudry, H ;
Rostène, W .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (04) :798-808
[7]   PRIMARY STRUCTURE OF FROG PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND EFFECTS OF OVINE PACAP ON FROG PITUITARY [J].
CHARTREL, N ;
TONON, MC ;
VAUDRY, H ;
CONLON, JM .
ENDOCRINOLOGY, 1991, 129 (06) :3367-3371
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis [J].
Di Matteo, Vincenzo ;
Esposito, Ennio .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (02) :95-107
[10]   Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling [J].
Falluel-Morel, A ;
Vaudry, D ;
Aubert, N ;
Galas, L ;
Benard, M ;
Basille, M ;
Fontaine, M ;
Fournier, A ;
Vaudry, H ;
Gonzalez, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2637-2642